TY - JOUR
AU - Rudan, Igor
AU - Adeloye, Davies
AU - Sheikh, Aziz
PY - 2022
DA - February
TI - COVID 19: vaccines, efficacy and effects on variants
JO - Current Opinion in Pulmonary Medicine
EP - 191
VL - 28
IS - 3
DO - https://doi.org/10.1097/mcp.0000000000000868
AB - PURPOSE OF REVIEW: We reviewed three leading strategies of vaccine development against coronavirus disease 2019 (COVID-19): mRNA vaccines, adenoviral vector vaccines and recombinant nanoparticles. We also considered the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and their impact on the effectiveness of the most widely implemented vaccines.
PB - Wolters Kluwer
UR - https://www.research.ed.ac.uk/en/publications/e3d4c8b1-a638-4531-8d11-c20d99ad1b0f
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER